X4 Pharmaceuticals (XFOR) Goodwill (2019 - 2025)

X4 Pharmaceuticals has reported Goodwill for 7 years, with the latest figure at $17.4 million in Q4 2025.

• For the quarter ending Q4 2025, Goodwill changed 0.0% year-over-year to $17.4 million; the trailing twelve-month figure through Dec 2025 stood at $17.4 million (changed 0.0% YoY), and the FY2025 full-year result was $17.4 million, changed 0.0% from the prior year.
• Goodwill for Q4 2025 stood at $17.4 million, roughly flat from $17.4 million in the prior quarter.
• The five-year high for Goodwill was $27.1 million in Q1 2021, with the low at $17.4 million in Q4 2021.
• Historically, Goodwill has averaged $18.8 million across 5 years, with a median of $17.4 million in 2021.
• The largest YoY upside for Goodwill was 0.0% in 2021 against a maximum downside of 36.0% in 2021.
• X4 Pharmaceuticals' Goodwill stood at $17.4 million in 2021, then changed by 0.0% to $17.4 million in 2022, then changed by 0.0% to $17.4 million in 2023, then changed by 0.0% to $17.4 million in 2024, then changed by 0.0% to $17.4 million in 2025.
• The last three Goodwill figures came in at $17.4 million (Q4 2025), $17.4 million (Q3 2025), and $17.4 million (Q2 2025), per Business Quant data.